Journal Article |
| Rajamani K, Chaturvedi S, Jin Z, Homma S, Brey RL, Tilley BC, Sacco RL, Thompson JL, Mohr JP, Levine SR. Patent Foramen Ovale, Cardiac Valve Thickening, and Antiphospholipid Antibodies as Risk Factors for Subsequent Vascular Events. The PICSS-APASS Study Stroke 2009 Jun;.
|
| Petri M, Naqibuddin M, Carson KA, Wallace DJ, Weisman MH, Holliday SL, Sampedro M, Narayana S, Fox PT, Franklin C, Padilla PA, Brey RL. Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus J Rheumatol 2008 Dec;35(12):2348-2354.
|
| Petri M, Naqibuddin M, Carson KA, Sampedro M, Wallace DJ, Weisman MH, Holliday SL, Padilla PA, Brey RL. Cognitive function in a systemic lupus erythematosus inception cohort J Rheumatol 2008 Sep;35(9):1776-1781.
|
| Muscal E, Brey RL. Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons Curr Rheumatol Rep 2008 Jan;10(1):67-73.
|
| Muscal E, Brey RL. Neurological manifestations of the antiphospholipid syndrome: risk assessments and evidence-based medicine Int J Clin Pract 2007 Sep;61(9):1561-1568.
|
| Roldan JF, Brey RL. Neurologic manifestations of the antiphospholipid syndrome Curr Rheumatol Rep 2007 May;9(2):109-115.
|
| Brey RL. Neuropsychiatric lupus: clinical and imaging aspects Bull NYU Hosp Jt Dis 2007 Jan;65(3):194-199.
|
| Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 2006 Feb;4(2):295-306.
|
| Brey RL. Antiphospholipid antibodies in young adults with stroke J Thromb Thrombolysis 2005 Oct;20(2):105-112.
|
| Brey RL. Patient Page. Both migraine and motion sickness may be due to low brain levels of serotonin Neurology 2005 Aug;65(4):9-10.
|
| Brey RL. Patient page. Exercise is safe and beneficial for people with facioscapulohumeral muscular dystrophy Neurology 2005 Mar;64(6):22-22.
|
| McLaurin EY, Holliday SL, Williams P, Brey RL. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus Neurology 2005 Jan;64(2):297-303.
|
| Brey RL. Patient page. Long-term obesity is linked to loss of brain tissue Neurology 2004 Nov;63(10):19-20.
|
| Brey RL. Patient Page. Clinical research needs YOU to help develop new cures! Neurology 2004 Jul;63(1):1-1.
|
| Zaccagni H, Fried J, Cornell JE, Padilla P, Brey RL. Soluble adhesion molecule levels, neuropsychiatric lupus and lupus-related damage Frontiers in Bioscience 2004 May;9:1654-1659.
|
| Levine SR, Brey RL, Tilley BC, Thompson JL, Sacco RL, Sciacca RR, Murphy A, Lu Y, Costigan TM, Rhine C, Levin B, Triplett DA, Mohr JP. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke JAMA 2004 Feb;291(5):576-584.
|
| Brey RL. Management of the neurological manifestations of APS--what do the trials tell us? Thromb Res 2004 Jan;114(5-6):489-499.
|
Abstract |
| McCoy KJ, McLaurin EY, Brey RL, Holliday SL. Intraindividual variability in cognitive performance in Systemic Lupus Erythematosus; 2006 Jan. (J of the International Neuropsychological Society; vol. 12, no. S1).
|
| Holliday, SL, Saklad, AR, Fischbach M, Garcia-Cavasos, R, Padilla PA, Brey RL. Risk Factors of Cognitive Dysfunction in SLE: San Antonio Lupus Study of Neuropsychiatric Disease (SALUD); 2004 Jan. (American Academy of Neurology 56th Annual Meeting Program; vol. 62, no. 7).
|
| McLaurin, EY, Holliday, SL, Brey RL. Predictors of Cognitive Functioning in Patients with Systemic Lupus Erythematosus; 2004 Jan. (American Academy of Neurology 56th Annual Meeting Program; vol. 62, no. 7).
|
| Naqibuddin, M, Wallace DJ, Weisman, MH, Holliday, SL, Wing, NF, Brey RL, Petri M. Cognitive Functioning in Recently-Diagnosed Systemic Lupus Erythematosus; 2004 Jan. (ACR/ARHP Program Book).
|
| Brey RL, Fox, PT, Narayana S, Martinez, MJ, Naqibuddin M, Holliday SL, Wallace DJ, Weisman MH, Petri M. Brain Imaging Findings in an SLE Inception Cohort: Brain CONECTIONS; 2004 Jan. (Arthritis & Rheumatism; vol. 50, no. 9).
|
Editorial |
| Brey RL. More on: fluvastatin inhibits upregulation of tissue factor expression by antiphospholipid antibodies on endothelial cells J Thromb Haemost 2005 Mar;3(3):616-616.
|
| Brey RL. New treatment option for the antiphospholipid antibody syndrome? More pleiotropic effects of the statin drugs J Thromb Haemost 2004 Sep;2(9):1556-1557.
|
Federal |
| Funding Agency |
NIH/NINDS |
| Title |
Neuropsychiatric Manifestations of Lupus Erythamatosis |
| Status |
Active |
| Period |
1/1996 - Present |
| Role |
Principal Investigator |
| Grant Detail |
Funded a VA NP Postdoc position for 4 years |
| Funding Agency |
NIH/NCRR |
| Title |
CTSA Program |
| Status |
Active |
| Period |
5/2008 - 4/2013 |
| Role |
Principal Investigator |
| Grant Detail |
|
| Funding Agency |
NIH, NCRR (UTHSCSA CTSA Application) |
| Title |
Institute for Integration of Medicine & Science: A Partnership to Improve Health. |
| Status |
Active |
| Period |
5/2008 - 4/2013 |
| Role |
Co-Principal Investigator |
| Grant Detail |
The University of Texas Health Science Center at San Antonio (UTHSCSA) established the Institute for Integration of Medicine and Science (IIMS) as the home for the Clinical and Translational Science Award (CTSA). Our mission is to achieve optimal integration of clinical and translational research, education, training, and career development across all UTHSCSA schools and among our partner organizations in the South Texas region. IIMS will focus existing and newly developing resources and intellectual capital on advancing the discipline of clinical and translational research for the improvement of human health. Within the context of our collective resources, community focus, and unique regional demographics, we have identified four Specific Aims as the core elements of our CTSA application: Aim 1- To support transformative clinical and translational research by providing a comprehensive infrastructure integrated effectively among our partners for the creation of multidisciplinary clinical research teams; Aim
2- To create the optimal intellectual environment and nurturing atmosphere necessary for the training of future clinical and translational career investigators, building upon existing strengths, partnerships, a diverse trainee pool and strong faculty dedication to mentoring; Aim 3- To develop community-based models that address the best means for translating research findings, focusing on our unique population-specific risk factors, disease burdens and health disparities; Aim 4- To implement robust tracking and outcome evaluation systems across all IIMS programs. The mission of IIMS is sharply focused on public health. Indeed, our primary vision is to work closely with all partners to translate the results of our academic and community-based research for the direct benefit of our regional population. |
| Funding Agency |
NIH - CTSA |
| Title |
Institute for Integration of Medicine & Science: A Partnership to Improve Health |
| Status |
Active |
| Period |
9/2009 - 8/2011 |
| Role |
Co-Investigator |
| Grant Detail |
The major goal of this Clinical and Translational Science Award (CTSA) is to create an Institute for Integration of Medicine and Science (IIMS) at UTHSCSA. Dr. Keller is responsible for coordinating Small Animal Imaging resources at the GCCRI and Director of the IIMS Small Animal Imaging Program. |
| Funding Agency |
NIH/NCRR |
| Title |
General Clinical Research Center |
| Status |
Active |
| Period |
4/2004 - 3/2009 |
| Role |
Consultant |
| Grant Detail |
The grant enables investigators to conduct research on human subjects in a research setting. I oversee the lab core that provides resources to investigators. The lab core consists of Bone Mineral Densitometry, Ultrasound and Blood and Urine sampling and processing |
| Funding Agency |
|
| Title |
Recurrent Stroke Prediction: Optimizing aPL-P Biomarkers |
| Status |
Active |
| Period |
7/2005 - 6/2008 |
| Role |
Co-Investigator |
| Grant Detail |
This application proposes to investigate the significance of antiphospholipid-protein (aPL-P) and ischemic stroke, specifically recurrent ischemic stroke and other thrombotic events. We will assay 2 aPL-P serum biomrkers currently used in clinical practice, with the goal to develop a battery ("portfolio") of immune-mediated increased thrombosis risk. |
| Funding Agency |
NIH/NCRR |
| Title |
CTSA Planning Grant |
| Status |
Complete |
| Period |
9/2006 - 9/2007 |
| Role |
Co-Investigator |
| Grant Detail |
|
| Funding Agency |
NIH |
| Title |
Neuropsychiatric Systemic Lupus Erythmatosus (Brain Connections) |
| Status |
Complete |
| Period |
7/2002 - 6/2007 |
| Role |
Co-Principal Investigator |
| Grant Detail |
The major goal of this project is to study risk factors for cognitive dysfunctin in an inception cohort of 100 SLE patients. Patients will be enrolled within 9 months of SLE diagnosis, adnwill b estudied for biomarkers, FDG-PET and anatomic MRI. the study design for this study is similar though not identical to the present study. |
| Funding Agency |
NIH/NINDS |
| Title |
Mid Career Investigator Award in Patient-Oriented Research (K24) |
| Status |
Active |
| Period |
5/2002 - 4/2007 |
| Role |
Co-Investigator |
| Grant Detail |
The major goal of this project is to determine the frequency of and risk for accelerated atherosclerosis in patients enrolled in funded NPSLE Cohort Study and determine the relationship between accelerated atherosclerosis and cerebrovascular ischemic events. |
Private |
| Funding Agency |
Lupus Foundation of America (LFA) Research Grant Award |
| Title |
Cognitive Impairment and White Matter Changes in Pediatric Lupus: Research Pilot Award |
| Status |
Active |
| Period |
9/2007 - 9/2009 |
| Role |
Principal Investigator |
| Grant Detail |
Mentor to Eyal Muscal, M.D. |
State |
| Funding Agency |
American College of Rheumatology REF/Lupus Research Institute |
| Title |
Assessment of Cognitive Dysfunction in Pediatric Lupus |
| Status |
Active |
| Period |
7/2007 - 6/2010 |
| Role |
Principal Investigator |
| Grant Detail |
Mentor to Eyal Muscal, M.D. |
| Funding Agency |
Baylor College of Medicine |
| Title |
K12 Child Health Research Career Development Award |
| Status |
Active |
| Period |
12/2008 - 11/2009 |
| Role |
Principal Investigator |
| Grant Detail |
Mentor to Eyal Muscal, M.D. |
